Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
J Pharm Sci ; 107(12): 3060-3069, 2018 12.
Article in English | MEDLINE | ID: mdl-30098991

ABSTRACT

This study demonstrates the preparation and characterization of ibuprofen (IBP) microparticles with some excipients by a controlled crystallization technique with improved dissolution performance. Using the optimum concentrations pluronic F127, hydroxypropyl methyl cellulose, D-mannitol, and l-leucine in aqueous ethanol, the IBP microparticles were prepared. The dissolution tests were performed in phosphate buffer saline using a United States Pharmacopoeia dissolution tester at 37°C. The Raman spectroscopy was used to investigate the interactions and distribution of the IBP with the additives in the microcrystals. The prepared IBP microparticles showed higher dissolution compared to that of the smaller sized original IBP particles. The Raman data revealed that the excipients with a large number of hydroxyl groups distributed around the IBP particle in the crystal enhanced the dissolution of the drug by increasing the drug-solvent interaction presumably through hydrogen bonding. The Raman mapping technique gave an insight into the enhanced dissolution behavior of the prepared IBP microparticles, and such information will be useful for developing pharmaceutical formulations of hydrophobic drugs. The controlled crystallization was a useful technique to prepare complex crystals of IBP microparticles along with other additives to achieve the enhanced dissolution profile.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/chemistry , Crystallization/methods , Drug Compounding/methods , Ibuprofen/chemistry , Chemical Precipitation , Excipients/chemistry , Freeze Drying , Hypromellose Derivatives/chemistry , Leucine/chemistry , Mannitol/chemistry , Particle Size , Poloxamer/chemistry , Solubility , Solvents/chemistry , Spectrum Analysis, Raman
2.
Eur J Pharm Biopharm ; 113: 118-131, 2017 Apr.
Article in English | MEDLINE | ID: mdl-28088005

ABSTRACT

This study reports the development of nanoparticles in the form of inhalable micro-aggregates of biodegradable chitosan (CS) loaded with nicotine hydrogen tartrate (NHT) for potential pulmonary delivery of nicotine from dry powder inhaler (DPI) formulations with prolonged release profile. The NHT-loaded CS particles were prepared using a water-in-oil emulsion crosslinking method. The prepared particles were characterized using scanning electron microscopy (SEM) and transmission electron microscopy (TEM) for morphological studies; Zetasizer and Mastersizer were applied for particle size analysis. The in vitro aerosolization of the formulations was studied using a twin-stage-impinger (TSI) and promising aerosolization characteristics were shown. The nanoparticles were spherical with size ranges between 167 and 411nm while micro-aggregates (3.73-4.73µm) were formed among nanoparticles. According to differential scanning calorimetry (DSC), X-ray diffraction (XRD) analysis and attenuated total reflectance-Fourier transform infrared (ATR-FTIR) spectroscopy, the NHT crystallinity was lost when in the particles, indicating it was uniformly dispersed as a solid solution. On the basis of X-ray photoelectron spectroscopy (XPS) analysis, the amount of NHT loaded on the surface of CS increased proportionally with increasing drug loading in the bulk so there was no surface enhancement. The fine particle doses (FPD) of NHT ranging between 1.7 and 3.2mg from DPI formulations were concentration dependent and increased with increased drug loading. Based on the in vitro release study, NHT released from CS particles with a burst release in the first 8h and subsequent prolonged release of nicotine.


Subject(s)
Chitosan/chemistry , Nanoparticles , Nicotine/administration & dosage , Calorimetry, Differential Scanning , In Vitro Techniques , Microscopy, Electron, Scanning , Microscopy, Electron, Transmission , Photoelectron Spectroscopy , Spectroscopy, Fourier Transform Infrared
3.
Mol Pharm ; 13(5): 1455-66, 2016 05 02.
Article in English | MEDLINE | ID: mdl-26998555

ABSTRACT

This study investigated l-leucine-conjugated chitosan as a drug delivery vehicle in terms of dispersibility and controlled release from a nanoparticulate dry powder inhaler (DPI) formulation for pulmonary delivery using diltiazem hydrochloride (DH) as the model drug. DH-loaded nanoparticles of chitosan and conjugate were prepared by water-in-oil emulsification followed by glutaraldehyde cross-linking. Nanoparticles were characterized by dynamic light scattering for particle size, X-ray photoelectron spectroscopy for surface composition, and twin stage impinger for drug dispersibility. The controlled release of DH was studied in phosphate-buffered saline (pH 7.3 ± 0.2, 37 °C) using UV spectrophotometry. The fine particle fractions of conjugated chitosan with and without drug were higher than those of nonconjugated chitosan nanoparticles. The conjugate nanoparticles were superior to those of unmodified chitosan in drug loading, entrapment efficiency, and controlled release profile. The higher dispersibility was attributed to the amphiphilic environment of the l-leucine conjugate and hydrophobic cross-links, and the release profile reflects the greater swelling. The conjugated chitosan nanoparticles could be useful, after appropriate testing for biodegradability and toxicity, as an alternative carrier for lung drug delivery with enhanced aerosolization and prolonged drug release from nanoparticulate DPI formulations.


Subject(s)
Chitosan/chemistry , Delayed-Action Preparations/chemistry , Leucine/chemistry , Nanoparticles/chemistry , Administration, Inhalation , Chemistry, Pharmaceutical/methods , Drug Carriers/chemistry , Drug Delivery Systems/methods , Drug Liberation/physiology , Dry Powder Inhalers/methods , Excipients/chemistry , Hydrogen-Ion Concentration , Hydrophobic and Hydrophilic Interactions , Particle Size , Photoelectron Spectroscopy/methods
4.
Biomacromolecules ; 15(10): 3596-607, 2014 Oct 13.
Article in English | MEDLINE | ID: mdl-25191851

ABSTRACT

Herein are reported the synthesis of a conjugate of chitosan with L-leucine, the preparation of nanoparticles from both chitosan and the conjugate for use in pulmonary drug delivery, and the in vitro evaluation of toxicity and inflammatory effects of both the polymers and their nanoparticles on the bronchial epithelial cell line, BEAS-2B. The nanoparticles, successfully prepared both from chitosan and the conjugate, had a diameter in the range of 10-30 nm. The polymers and their nanoparticles were tested for their effects on cell viability by MTT assay, on trans-epithelial permeability by using sodium fluorescein as a fluid phase marker, and on IL-8 secretion by ELISA. The conjugate nanoparticles had a low overall toxicity (IC50 = 2 mg/mL following 48 h exposure; no induction of IL-8 release at 0.5 mg/mL concentration), suggesting that they may be safe for pulmonary drug delivery applications.


Subject(s)
Chitosan/administration & dosage , Chitosan/chemistry , Leucine/administration & dosage , Leucine/chemistry , Lung/metabolism , Cell Line , Cell Survival/drug effects , Chitosan/adverse effects , Drug Carriers/administration & dosage , Drug Carriers/adverse effects , Drug Carriers/chemistry , Drug Delivery Systems/methods , Epithelial Cells/drug effects , Epithelial Cells/metabolism , Humans , Interleukin-8/metabolism , Leucine/adverse effects , Lung/drug effects , Nanoparticles/administration & dosage , Nanoparticles/adverse effects , Nanoparticles/chemistry , Particle Size , Permeability , Polymers/administration & dosage , Polymers/adverse effects , Polymers/chemistry
5.
J Biomed Mater Res A ; 100(7): 1919-27, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22581620

ABSTRACT

This study investigates the effect of well-defined poly(dimethylsiloxane)-poly(ethylene glycol) (PDMS-PEG) ABA linear block co-oligomers on the proliferation of human dermal fibroblasts. The co-oligomers assessed ranged in molecular weight (MW) from 1335 to 5208 Da and hydrophilic-lipophilic balance (HLB) from 5.9 to 16.6 by varying the number of both PDMS and PEG units. In general, it was found that co-oligomers of low MW or intermediate hydrophilicity significantly reduced fibroblast proliferation. A linear relationship between down-regulation of fibroblast proliferation, and the ratio HLB/MW was observed at concentrations of 0.1 and 1.0 wt % of the oligomers. This enabled the structures with highest efficiency to be determined. These results suggest the possible use of the PEG-PDMS-PEG block co-oligomers as an alternative to silicone gels for hypertrophic scar remediation.


Subject(s)
Siloxanes/pharmacology , Skin/drug effects , Cell Proliferation/drug effects , Cells, Cultured , Fibroblasts/drug effects , Humans , Siloxanes/chemistry , Skin/cytology
6.
Pharm Res ; 29(9): 2445-55, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22584947

ABSTRACT

PURPOSE: To study the effect of the size of the surface-coated polycaprolactone (PCL) microparticle carriers on the aerosolization and dispersion of Salbutamol Sulfate (SS) from Dry Powder Inhaler (DPI) formulations. METHODS: The microparticles were fabricated using an emulsion technique in four different sizes (25, 48, 104 and 150 µm) and later coated with Magnesium stearate (MgSt) and leucine. They were characterized by laser diffraction and SEM. The Fine Particle Fraction (FPF) of SS from powder mixtures was determined by a Twin Stage Impinger (TSI). RESULTS: As the carrier size increased from 25 µm to 150 µm, the FPF of the SS delivered by the coated PCL particles increased approximately four fold. A linear relationship was found between the FPF and Volume mean Diameter (VMD) of the particles over this range. CONCLUSIONS: The dispersion behaviour of SS from PCL carriers was dependent on the inherent size of the carriers and the increased FPF of SS with increased carrier size probably reflects the higher mechanical forces produced due to the carrier-carrier collisions or collisions between the carrier particles and the internal walls of the inhaler during aerosolization.


Subject(s)
Albuterol/administration & dosage , Bronchodilator Agents/chemistry , Dry Powder Inhalers , Microspheres , Polyesters/chemistry , Drug Carriers , Microscopy, Electron, Scanning , Particle Size , Polyesters/administration & dosage
7.
J Pharm Sci ; 101(2): 733-45, 2012 Feb.
Article in English | MEDLINE | ID: mdl-21956254

ABSTRACT

This study reports the factors controlling aerosolization of salbutamol sulfate (SS) from mixtures with polycaprolactone (PCL) microspheres fabricated using an emulsion technique with polyvinyl alcohol (PVA) as stabilizer. The fine particle fraction (FPF) of SS from PCL measured by a twin-stage impinger was unexpectedly found to be zero, although scanning electron microscopy showed that the drug coated the entire microsphere. Precoating the microspheres with magnesium stearate (MgSt) excipient solutions (1%-2%) significantly increased (p < 0.05, n = 5) the FPF of SS (11.4%-15.4%), whereas precoating with leucine had a similar effect (FPF = 11.3 ± 1.1%), but was independent of the solution concentration. The force of adhesion (by atomic force microscopy) between the PCL microspheres and SS was reduced from 301.4 ± 21.7 nN to 110.9 ± 30.5 nN and 121.8 ± 24.6 nN, (p < 0.05, n = 5) for 1% and 2% MgSt solutions, respectively, and to 148.1 ± 21.0 nN when coated with leucine. The presence of PVA on the PCL microspheres (detected by X-ray photoelectron spectroscopy) affected the detachment of SS due to strong adhesion between the two, presumably due to capillary forces acting between them. Precoating the microspheres with excipients increased the FPF significantly by reducing the drug-carrier adhesion.


Subject(s)
Aerosols , Albuterol/administration & dosage , Bronchodilator Agents/administration & dosage , Dry Powder Inhalers , Microspheres , Polyesters/chemistry , Chromatography, High Pressure Liquid , Microscopy, Electron, Scanning , Particle Size , Spectrometry, X-Ray Emission
8.
J Biomed Mater Res A ; 95(2): 620-31, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20725963

ABSTRACT

The formation of hypertrophic scars (HSF) is a frequent medical outcome of wound repair and often requires further therapy with treatments such as silicone gel sheets (SGS) or apoptosis-inducing agents, including bleomycin. Although widely used, knowledge regarding SGS and their mode of action is limited. Preliminary research has shown that small amounts of amphiphilic silicone present in SGS have the ability to move into skin during treatment. We demonstrate herein that a commercially available analogue of these amphiphilic siloxane species, the rake copolymer GP226, decreases collagen synthesis on exposure to cultures of fibroblasts derived from HSF. By size exclusion chromatography, GP226 was found to be a mixture of siloxane species, containing five fractions of different molecular weight. By studies of collagen production, cell viability and proliferation, it was revealed that a low molecular weight fraction (fraction IV) was the most active, reducing the number of viable cells present after treatment and thereby reducing collagen production as a result. On exposure of fraction IV to human keratinocytes, viability and proliferation were also significantly affected. HSF undergoing apoptosis after application of fraction IV were also detected via real-time microscopy and by using the TUNEL assay. Taken together, these data suggests that these amphiphilic siloxanes could be potential non-invasive substitutes to apoptotic-inducing chemical agents that are currently used as scar treatments.


Subject(s)
Apoptosis/drug effects , Cell Proliferation/drug effects , Fibroblasts , Keratinocytes , Siloxanes/pharmacology , Surface-Active Agents/pharmacology , Biocompatible Materials/chemistry , Biocompatible Materials/pharmacology , Cell Survival/drug effects , Cells, Cultured , Cicatrix, Hypertrophic/pathology , Coculture Techniques , Fibroblasts/cytology , Fibroblasts/drug effects , Fibroblasts/physiology , Humans , Keratinocytes/cytology , Keratinocytes/drug effects , Keratinocytes/physiology , Materials Testing
9.
Biomaterials ; 29(12): 1785-95, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18241915

ABSTRACT

Chronic ulcers are an important and costly medical issue, imposing considerable pain, reduced mobility and decreased quality of life. The common pathology in these chronic wounds is excessive proteolytic activity, resulting in degradation of key factors critical to the ulcer's ability to heal. Matrix metalloproteinases (MMPs), a large family of zinc-dependent endopeptidases, have been shown to have increased activity in chronic wound fluid (CWF), with many authors suggesting that they need to be inhibited for the ulcer to heal. The studies we report here show that the excessive MMP activity in CWF can be inhibited with the bisphosphonate alendronate, in the form of a sodium salt, a functionalised analogue, and tethered to a poly(2-hydroxy methacrylate) (PHEMA) hydrogel. Furthermore, these functionalised alendronate hydrogels appear to be biologically inert as assessed in a three-dimensional ex vivo human skin equivalent model. Together, these results highlight the potential use of a tethered MMP inhibitor to inhibit protease activity in wound fluid. This approach may improve wound healing as it still allows MMPs to remain active in the upper cellular layers of the ulcer bed where they perform vital roles in wound healing; thus may offer an attractive new device-orientated wound therapy.


Subject(s)
Body Fluids/metabolism , Diphosphonates/administration & dosage , Drug Carriers/chemistry , Hydrogels/chemistry , Matrix Metalloproteinase Inhibitors , Ulcer/drug therapy , Ulcer/enzymology , Wound Healing/drug effects , Diphosphonates/chemistry , Enzyme Activation/drug effects , Humans , Materials Testing
10.
J Nanosci Nanotechnol ; 7(10): 3477-86, 2007 Oct.
Article in English | MEDLINE | ID: mdl-18330161

ABSTRACT

Raw and purified samples of carbon nanotubes are considered as multicomponent systems with a distribution of carbonaceous, amorphous, multishell graphitic particles and nanotubes, together with the particles of metal compounds from the catalyst. With respect to the carbon nanotube fractions, a distribution of size, defect concentrations, and functionalities needs to be taken into account. In order to address the problem of quantitative evaluation of purity it is necessary to measure the quality and distribution of the carbon nanotubes. In this research conventional and high resolution thermogravimetry are applied to quantify different fractions of carbonaceous and metallic materials in raw and moderately purified single walled and multiwalled carbon nanotubes. For each oxidized fraction, defined by careful line shape analysis of the derivative thermogravimetric curves (DTG), the temperature of maximum rate of oxidation, the temperature range for this oxidation, related to the degree of homogeneity, and the amount of associated material is specified. The attribution of carbonaceous materials to each fraction in the distribution was based on SEM and TEM measurements and the literature. The MWNT purified sample with 1.6 wt% metal oxide was investigated by high resolution thermogravimetry (HRTG). The quantitative assessment for the carbonaceous fractions was 25 wt% of amorphous and high defect carbonaceous materials including nanotubes, 54 wt% MWNT and 20 wt% multishell graphitic particles. A qualitative evaluation of these fractions was obtained from the SEM and TEM images and supports these results. The accuracy of the values, taking into account other measurements performed on the same batch of material, should be more sensible than +/-4 wt%.


Subject(s)
Crystallization/methods , Materials Testing/methods , Microscopy, Electron, Scanning/methods , Microscopy, Electron, Transmission/methods , Nanotubes, Carbon/chemistry , Nanotubes, Carbon/ultrastructure , Thermogravimetry/methods , Macromolecular Substances/chemistry , Molecular Conformation , Nanotechnology/methods , Particle Size , Surface Properties
SELECTION OF CITATIONS
SEARCH DETAIL
...